These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 6144130

  • 1. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study of efficacy and withdrawal.
    Fontaine R, Chouinard G, Annable L.
    Psychopharmacol Bull; 1984; 20(1):126-7. PubMed ID: 6144130
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy and withdrawal of two potent benzodiazepines: bromazepam and lorazepam.
    Fontaine R, Annable L, Beaudry P, Mercier P, Chouinard G.
    Psychopharmacol Bull; 1985; 21(1):91-2. PubMed ID: 2858908
    [No Abstract] [Full Text] [Related]

  • 4. Bromazepam, a new anxiolytic: a comparative study with diazepam in general practice. Royal College of General Practitioners Medicines Surveillance Organisation.
    Royal College of General Practitioners Medicines Surveillance Organisation.
    J R Coll Gen Pract; 1984 Sep; 34(266):509-12. PubMed ID: 6147412
    [Abstract] [Full Text] [Related]

  • 5. A comparison between bromazepam (Ro 5-3350, Lexotan) and diazepam (Valium) in anxiety neurosis. A controlled, double-blind clinical trial.
    Sonne LM, Holm P.
    Int Pharmacopsychiatry; 1975 Sep; 10(2):125-8. PubMed ID: 237849
    [Abstract] [Full Text] [Related]

  • 6. [Bromazepam(Lexotan) and chlorprothixene(Taractan) in psychoneurotic anxiety states. A randomized, double-blind study from general practice concerning the effect, drug consumption, and risk of repeated treatment].
    Fynboe C, Christensen N, Halberg T, Hansen EA, Holm P, Knudsen JP, Lindhardt J, Maul B, Musaeus C, Nielsen MT, Schaumburg E.
    Ugeskr Laeger; 1981 Oct 05; 143(41):2641-5. PubMed ID: 6117963
    [No Abstract] [Full Text] [Related]

  • 7. [Alprazolam (Tafil) and bromazepam (Lexotan) in the treatment of anxiety. A randomized, double-blind comparison in psychiatric outpatients].
    Sonne LM, Bruun-Hansen J.
    Ugeskr Laeger; 1986 Jun 02; 148(23):1392-5. PubMed ID: 2873673
    [No Abstract] [Full Text] [Related]

  • 8. [Anxiety states and bromazepam (author's transl)].
    Ferreri M, Alby JM.
    Nouv Presse Med; 1982 May 13; 11(22):1728-30. PubMed ID: 6124944
    [Abstract] [Full Text] [Related]

  • 9. A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis.
    Lapierre YD, Tremblay A, Gagnon A, Monpremier P, Berliss H, Oyewumi LK.
    J Clin Psychiatry; 1982 Sep 13; 43(9):372-4. PubMed ID: 6126475
    [Abstract] [Full Text] [Related]

  • 10. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder.
    Ballenger JC, McDonald S, Noyes R, Rickels K, Woods SW, Patin J, Lydiard B, Garvey M, Cook B, Goodard AW.
    Adv Biochem Psychopharmacol; 1992 Sep 13; 47():431-47. PubMed ID: 1354920
    [No Abstract] [Full Text] [Related]

  • 11. Benzodiazepine effect on information processing in generalized anxiety disorder.
    Lapierre YD, Butter HJ, Oyewumi LK.
    Neuropsychobiology; 1983 Sep 13; 9(2-3):88-93. PubMed ID: 6137786
    [Abstract] [Full Text] [Related]

  • 12. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
    Cohn JB.
    J Clin Psychiatry; 1981 Sep 13; 42(9):347-51. PubMed ID: 6115853
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.
    J Clin Psychopharmacol; 1993 Dec 13; 13(6):429-37. PubMed ID: 7907097
    [Abstract] [Full Text] [Related]

  • 14. Bromazepam ('Lexotanil') compared with placebo: a double-blind, crossover study.
    Rey A, Bovet J, Schneider PB.
    Pharmatherapeutica; 1984 Dec 13; 4(1):13-20. PubMed ID: 6150491
    [Abstract] [Full Text] [Related]

  • 15. Etizolam in the treatment of generalized anxiety disorder: a controlled clinical trial.
    Bertolino A, Mastucci E, Porro V, Corfiati L, Palermo M, Ecari U, Ceccarelli G.
    J Int Med Res; 1989 Dec 13; 17(5):455-60. PubMed ID: 2572494
    [Abstract] [Full Text] [Related]

  • 16. [Bromazepam versus placebo. Double-blind crossover study].
    Rey A, Bovet J, Schneider PB.
    Schweiz Rundsch Med Prax; 1984 Jan 31; 73(5):143-8. PubMed ID: 6142517
    [No Abstract] [Full Text] [Related]

  • 17. A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder.
    Feighner JP, Merideth CH, Hendrickson GA.
    J Clin Psychiatry; 1982 Dec 31; 43(12 Pt 2):103-8. PubMed ID: 6130066
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P, Touchon J, Billardon M.
    Encephale; 1997 Dec 31; 23(4):290-9. PubMed ID: 9417395
    [Abstract] [Full Text] [Related]

  • 19. Alprazolam and diazepam in the treatment of generalized anxiety.
    Elie R, Lamontagne Y.
    J Clin Psychopharmacol; 1984 Jun 31; 4(3):125-9. PubMed ID: 6145726
    [Abstract] [Full Text] [Related]

  • 20. [Bromazepam withdrawal delirium - a psychopharmacological contribution to clinical withdrawal syndromes (author's transl)].
    Böning J.
    Nervenarzt; 1981 May 31; 52(5):293-7. PubMed ID: 6113557
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.